MSB 2.34% 93.8¢ mesoblast limited

News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat, page-128

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    "That's why MSB is at the frontier. Our stem cells are leading the way. "

    This is why you have been losing money for a decade, you fail to see you are being surpassed by Gen 2 and Gen 3 as we speak.....

    The only advantage Meso had was first to market...that has been dealt multiple blows recently, so that "advantage" of "time" is disappearing fast as you have to re-do trials agin.

    Certainly don't have the best manufacturing or the best cells being BM derived. Far from it.
    A ton of research proving more effective cells coming on the market

    That's delusional speak that could only come from a rigid baked on believer.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
93.8¢
Change
-0.023(2.34%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.110M 1.173M

Buyers (Bids)

No. Vol. Price($)
36 96246 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.0¢ 35916 43
View Market Depth
Last trade - 15.36pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.